Table II.
Subset analysis of OS time (n=52).
| Variables | No. of patients | Median OS (months) | 95% CI | χ2 | P-value |
|---|---|---|---|---|---|
| Menstruation | 0.000 | 0.987 | |||
| Pre | 28 | 13.3 | 7.1–19.5 | ||
| Post | 24 | 12.5 | 8.3–16.7 | ||
| Clinical stage | 6.668 | 0.010 | |||
| IIC | 16 | 22.7 | 4.4–41.0 | ||
| III | 36 | 11.3 | 8.6–14.0 | ||
| Histological type | 0.000 | 0.993 | |||
| Infiltrating ductal | 40 | 13.3 | 8.9–17.7 | ||
| Others | 12 | 12.3 | 2.7–21.9 | ||
| Number of organs involved | 3.923 | 0.048 | |||
| 1 | 20 | 15.7 | 5.6–25.8 | ||
| ≥2 | 32 | 11.3 | 9.3–13.3 | ||
| Previous chemotherapya | 0.193 | 0.661 | |||
| Yes | 30 | 14.5 | 5.0–24.0 | ||
| No | 22 | 12.5 | 7.4–17.6 |
a
Anthracycline or taxane. OS, overall survival; CI, confidence interval.